Fecal calprotectin: evaluating its importance in monitoring Inflammatory Bowel Disease

被引:0
|
作者
Kyle, Barry
Agbor, Terence
Usha, Chauhan
Halder, Smita
Khan, Waliul
机构
[1] DynaLIFE Med Labs, Edmonton, AB, Canada
[2] Dept Gastroenterol, Hamilton, ON, Canada
[3] McMaster Univ, Hamilton, ON, Canada
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
P115
引用
收藏
页码:89 / 89
页数:1
相关论文
共 50 条
  • [41] The comparison of the three assays for determination of fecal calprotectin in inflammatory bowel disease
    Osredkar, Josko
    Kurent, Tina
    Fabjan, Teja
    Kumer, Kristina
    Alic, Elizabeta Boznar
    Drobne, David
    BIOCHEMIA MEDICA, 2021, 31 (02) : 020707
  • [42] Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease
    Shimizu, Hirotaka
    Ebana, Ryo
    Kudo, Takahiro
    Sato, Takuro
    Hara, Tomoko
    Hosoi, Kenji
    Usami, Masaaki
    Yoshida, Masashi
    Takeuchi, Ichiro
    Nakase, Hiroshi
    Iwama, Itaru
    Arai, Katsuhiro
    Shimizu, Toshiaki
    JOURNAL OF GASTROENTEROLOGY, 2022, 57 (05) : 344 - 356
  • [43] Comparison of Fecal Calprotectin and Myeloperoxidase in Predicting Outcomes in Inflammatory Bowel Disease
    Swaminathan, A.
    Borichevsky, G. M.
    Frampton, C. M.
    Day, A. S.
    Hampton, M. B.
    Kettle, A. J.
    Gearry, R. B.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [44] Is fecal calprotectin the next standard in inflammatory bowel disease activity tests?
    Alic, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (11): : 3370 - 3371
  • [45] FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
    Rosenfeld, Greg
    Greenup, Astrid-Jane
    Round, Andrew
    Takach, Oliver
    Halparin, Lawrence
    Saadeddin, Abid
    Ho, Jin Kee
    Lee, Terry
    Enns, Robert
    Bressler, Brian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (36) : 8211 - 8218
  • [46] Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease
    Konikoff, Michael R.
    Denson, Lee A.
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (06) : 524 - 534
  • [47] FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
    Greg Rosenfeld
    Astrid-Jane Greenup
    Andrew Round
    Oliver Takach
    Lawrence Halparin
    Abid Saadeddin
    Jin Kee Ho
    Terry Lee
    Robert Enns
    Brian Bressler
    World Journal of Gastroenterology, 2016, (36) : 8211 - 8218
  • [48] Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment
    Bertani, Lorenzo
    Mumolo, Maria Gloria
    Tapete, Gherardo
    Albano, Eleonora
    Svizzero, Giovanni Baiano
    Zanzi, Federico
    Ceccarelli, Linda
    Bellini, Massimo
    Marchi, Santino
    Costa, Francesco
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (09) : 1091 - 1098
  • [49] Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
    D'Haens, Geert
    Ferrante, Marc
    Vermeire, Severine
    Baert, Filip
    Noman, Maja
    Moortgat, Liesbeth
    Geens, Patricia
    Iwens, Doreen
    Aerden, Isolde
    Van Assche, Gert
    Van Olmen, Gust
    Rutgeerts, Paul
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) : 2218 - 2224
  • [50] Fecal Calprotectin and Lactoferrin as Noninvasive Markers of Pediatric Inflammatory Bowel Disease
    Joishy, Manohara
    Davies, Ieuan
    Ahmed, Mansoor
    Wassel, Julie
    Davies, Karen
    Sayers, Adrian
    Jenkins, Huw
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2009, 48 (01): : 48 - 54